山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (5): 1-7.doi: 10.6040/j.issn.1671-7554.0.2016.1506
• 基础医学 • 下一篇
宋昱1,毛洋1,刘庆梅2,乔磊1,帖媛媛1,鲁璐3,张蕾1
SONG Yu1, MAO Yang1, LIU Qingmei2, QIAO Lei1, TIE Yuanyuan1, LU Lu3, ZHANG Lei1
摘要: 目的 在兔腹主动脉粥样易损斑块硬化模型中,以辛伐他汀作为阳性对照,进一步明确通心络对易损斑块三维应变的影响。 方法 50只纯种雄性新西兰大白兔行腹主动脉球囊拉伤,1%胆固醇饲料喂养10周,改为普通饲料继续喂养8周,并随机分为对照组、小剂量通心络组[0.15 g/(kg·d)]、中剂量通心络组[0.3 g/(kg·d)]、高剂量通心络组[0.6 g/(kg·d)]和辛伐他汀组[5 mg/(kg·d)],每组10只。18周末采用酶法检测其血脂水平,并行体表三维超声及血管内超声检查,处死动物,取腹主动脉脱水,包埋制石蜡及冰冻切片,行苏木精-伊红染色、组织病理学染色以及免疫组织化学染色。 结果 在通心络和辛伐他汀药物干预下,中、大剂量通心络组及辛伐他汀组动脉粥样硬化斑块的周向(CSp)和轴向应变峰值(RSp)降低,而纵向应变峰值(LSp)升高,斑块面积和斑块负荷减小。同时,中、大剂量通心络及辛伐他汀干预可以减少斑块内巨噬细胞含量,降低斑块易损指数,并且减少斑块内基质金属蛋白酶2、9(MMP-2, MMP-9)的表达。 结论 通心络和辛伐他汀可通过抑制斑块内巨噬细胞含量及MMP-2、MMP-9表达影响斑块的三维应变,稳定动脉粥样硬化斑块,其稳定斑块作用可通过检测斑块三维应变进行无创监测。
中图分类号:
[1] Xiao W, Jia Z, Zhang Q, et al. Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis[J]. Mol Med Rep, 2015, 12(3): 3315-3322. [2] Michel JB, Martin-Ventura JL, Nicoletti A, et al. Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages[J]. Atherosclerosis, 2014, 234(2): 311-319. [3] Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque[J]. Arterioscler Thromb Vasc Biol, 2010, 30(7): 1282-1292. [4] Lendon CL, Davies MJ, Richardson PD, et al. Testing of small connective tissue specimens for the determination of the mechanical behaviour of atherosclerotic plaques[J]. J Biomed Eng, 1993, 15(1): 27-33. [5] Chan PS, Nallamothu BK, Gurm HS, et al. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease[J]. Circulation, 2007, 115(18): 2398-2409. [6] 郑博, 王新刚, 龚艳君, 等. 直接经皮冠状动脉介入治疗术前负荷剂量阿托伐他汀治疗对急性心肌梗死患者近期预后的影响[J]. 中国介入心脏病学杂志, 2013, 21(1): 41-45. ZHENG Bo, WANG Xingang, GONG Yanjun, et al. Impact of high loading-dose atorvastatin pre-treatment before primary percutaneous coronary intervention on coronary flow in patients with ST segment elevation myocardial infarction[J]. Chin J Intervent Cardiol, 2013, 21(1): 41-45. [7] Ma L, Ni M, Hao PP, et al. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice[J]. Oncotarget, 2016, 7(13): 16194-16204 [8] Zheng CY, Song LL, Wen JK, et al. Tongxinluo(TXL), a traditional Chinese medicinal compound, improves endothelial function after chronic hypoxia both in vivo and in vitro[J]. J Cardiovasc Pharmacol, 2015, 65(6): 579-586. [9] Zhang L, Liu Y, Lu XT, et al. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy[J]. Am J Physiol Heart Circ Physiol, 2009, 297(6): 2004-2014. [10] Cannesson M, Tanabe M, Suffoletto MS, et al. Velocity vector imaging to quantify ventricular dyssynchrony and predict response to cardiac resynchronization therapy[J]. Am J Cardiol, 2006, 98(7): 949-953. [11] Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture[J]. Circulation, 1994, 90(2): 775-778. [12] Ji QW, Guo M, Zheng JS, et al. Downregulation of T helper cell type 3 in patients with acute coronary syndrome[J]. Arch Med Res, 2009, 40(4): 285-293. [13] Liu XQ, Mao Y, Wang B, et al. Specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits[J]. PLoS One, 2014, 9(9):107851. doi: 10.1371/journal.pone.0107851. [14] 顾菲菲, 吕树铮, 陈韵岱, 等. 血管内超声技术对不稳定性心绞痛患者冠状动脉临界病变形态学评价[J]. 中国介入心脏病学杂志, 2011, 19(3): 125-128. GU Feifei, LÜ Shuzheng, CHEN Yundai, et al. Evaluation of plaque morphology of coronary borderline lesions in unstable angina patients by intravascular ultrasound[J]. Chin J Intervent Cardiol, 2011, 19(3): 125-128. [15] Gijsen FJ, Wentzel JJ, Thury A, et al. Strain distribution over plaques in human coronary arteries relates to shear stress[J]. Am J Physiol Heart Circ Physiol, 2008, 295(4):1608-1614. [16] 张梅. 动脉粥样硬化斑块无创性超声检测方法[J]. 中国医学前沿杂志(电子版), 2013, 5(4): 35-37. [17] van der Wal AC, Becker AE. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability[J]. Cardiovasc Res, 1999, 41(2): 334-344. [18] Waltenberger J. Pathophysiological bases of unstable coronary syndrome[J]. Herz, 2001, 26(Suppl 1): 2-8. [19] Zhang L, Liu Y, Zhang PF, et al. Peak radial and circumferential strain measured by velocity vector imaging is a novel index for detecting vulnerable plaques in a rabbit model of atherosclerosis[J]. Atherosclerosis, 2010, 211(1): 146-152. |
[1] | 高秀蕊 臧恒昌. 复方烟酸辛伐他汀双层片体外释放度的研究[J]. 山东大学学报(医学版), 2209, 47(6): 109-113. |
[2] | 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 49-55. |
[3] | 樊彦伟,严冬雪,招友. 富氢水对兔腰椎间盘退变的影响[J]. 山东大学学报(医学版), 2017, 55(3): 38-42. |
[4] | 王伟,曹煜姗,孙达权,黄小琼,徐国强. 人TIMP-2蛋白在肝癌细胞迁移与侵袭中的作用[J]. 山东大学学报(医学版), 2016, 54(7): 11-17. |
[5] | 巨媛媛,任满意,李睿,赵萌萌,隋树建. TWEAK通过ERK1/2通路促进大鼠心肌成纤维细胞MMP2与Ⅰ型胶原表达[J]. 山东大学学报(医学版), 2016, 54(5): 23-28. |
[6] | 徐延杰,崔谊,李红霞,史文琦,李福艳,王建震,曾庆师. X线照射对U87胶质瘤多细胞球体MMP-2活性及Cho/Cr的影响[J]. 山东大学学报(医学版), 2016, 54(4): 6-10. |
[7] | 王聪, 孙书珍, 甄军晖, 李倩, 许艺怀. CXCL16在阿霉素肾病小鼠中的表达及辛伐他汀对其的影响[J]. 山东大学学报(医学版), 2015, 53(9): 24-29. |
[8] | 吕树卿, 尉蔚, 张灿灿, 田永杰. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报(医学版), 2015, 53(7): 1-7. |
[9] | 杨娟, 邱宗建, 宋强. 辛伐他汀对急性髓系白血病NB4细胞株DNA甲基转移酶的影响[J]. 山东大学学报(医学版), 2015, 53(6): 28-32. |
[10] | 于磊, 李振. 白细胞介素33在脑血管病患者血清中的表达及其作用机制[J]. 山东大学学报(医学版), 2015, 53(4): 75-79. |
[11] | 林锦秀, 孙东升, 郑潇, 尹德超, 李晔, 张磊. 局部应用辛伐他汀促进前交叉韧带重建骨隧道腱骨愈合的效应[J]. 山东大学学报(医学版), 2015, 53(3): 27-31. |
[12] | 张伶俐, 周莹, 李小荷, 李慧, 钟明, 张薇. 中国房颤人群心肌组织中MMPs与TIMPs的mRNA表达水平的Meta分析[J]. 山东大学学报(医学版), 2015, 53(1): 47-53. |
[13] | 涂燕, 李振江, 汤爱平, 费妍, 李慧慧, 李剑, 贺文凤. 干扰CD147表达抑制白血病细胞SHI-1增殖及移行[J]. 山东大学学报(医学版), 2014, 52(9): 1-5. |
[14] | 石焕1,2,邵倩倩1,孙锦堂1,宋丙凤1,吕静1,3,何影1,张韵1,曲迅1. 罗勒多糖对乳腺癌细胞系MDA-MB-231侵袭的影响[J]. 山东大学学报(医学版), 2013, 51(9): 50-54. |
[15] | 毕大鹏1,嵇高德1,张洪星2 . 通心络胶囊对早期糖尿病肾病患者胱抑素C的影响[J]. 山东大学学报(医学版), 2013, 51(7): 67-69. |
|